๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical trial of tamoxifen in patients with irresectable pancreatic adenocarcinoma

โœ Scribed by Mr. O. M. Taylor; E. A. Benson; M. J. McMahon

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
339 KB
Volume
80
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A clinical trial of intravenous vinorelb
A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in the treatment of patients with advanced malignant melanoma
โœ Lynn G. Feun; Niramol Savaraj; Judith Hurley; Angela Marini; Shenghan Lai ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 65 KB ๐Ÿ‘ 2 views

## BACKGROUND. The aim of the current trial was to assess the efficacy and toxicity of weekly intravenous vinorelbine tartrate with daily oral tamoxifen in the treatment of patients with advanced or metastatic malignant melanoma. ## METHODS. Thirty-one patients were treated with vinorelbine tartr

Ultrasound scanning in patients with cli
Ultrasound scanning in patients with clinical suspicion of pancreatic cancer: A retrospective study
โœ Daniel Pollock; Kenneth J. W. Taylor ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 418 KB ๐Ÿ‘ 2 views

A retrospective study was performed on all patients with clinical suspicion of a pancreatic cancer over a seven-month period. Diagnostic scans of the pancreas were obtained in 87% of the patients. Of 112 patients with a successful ultrasound study, 97 had adequate clinical or surgical follow up. The

Randomized clinical trial of folate supp
Randomized clinical trial of folate supplementation in patients with peripheral arterial disease
โœ N. Khandanpour; M. P. Armon; B. Jennings; P. M. Finglas; G. Willis; A. Clark; F. ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 141 KB ๐Ÿ‘ 1 views

## Abstract ## Background The aim was to determine whether folate supplementation improved arterial function in patients with peripheral arterial disease (PAD). ## Methods Individuals with PAD were randomly assigned to receive 400 ยตg folic acid (45 patients) or 5-methyltetrahydrofolate (5-MTHF)